Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| UNITED THERAPEUTICS CorpUTHR · Entity 664 | PRESIDENT AND COO | May 13, 2026 | May 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
UNITED THERAPEUTICS Corp
Report date May 13, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $217.50 · Expires 2033-03-15 | Direct | 0 |
Reported balance
After 2026-05-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-13 · Gift · Disposed 11,728 · Balance 0 F1: On March 13, 2026, the Reporting Person transferred stock options to a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $217.50 · Expires 2033-03-15 | Indirectby Trust | 99,720 |
Reported balance
After 2026-05-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-13 · Gift · Acquired 11,728 · Balance 99,720 F1: On March 13, 2026, the Reporting Person transferred stock options to a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power. F2: Held in trusts beneficially owned by the Reporting Person, of which the Reporting Person or his family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 13, 2026, the Reporting Person transferred stock options to a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.
F2: Held in trusts beneficially owned by the Reporting Person, of which the Reporting Person or his family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 02, 2021 Filed Nov 3, 2021 20:37 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-028302 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:37 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $192.20 | $768,800.00 |
DisclosureSEC source: 0001127602-21-028302 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:37 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-028302 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-027818 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $192.17 | $768,680.00 |
DisclosureSEC source: 0001127602-21-027818 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-027818 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 26, 2021 Filed Oct 27, 2021 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-027700 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 26, 2021 Filed Oct 27, 2021 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $190.45 | $761,800.00 |
DisclosureSEC source: 0001127602-21-027700 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 26, 2021 Filed Oct 27, 2021 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-027700 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 21, 2021 Filed Oct 22, 2021 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-027489 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 21, 2021 Filed Oct 22, 2021 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $190.66 | $762,640.00 |
DisclosureSEC source: 0001127602-21-027489 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 21, 2021 Filed Oct 22, 2021 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-027489 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 07, 2021 Filed Oct 8, 2021 21:08 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-026868 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 07, 2021 Filed Oct 8, 2021 21:08 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $195.94 | $783,760.00 |
DisclosureSEC source: 0001127602-21-026868 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 07, 2021 Filed Oct 8, 2021 21:08 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-026868 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 23, 2021 Filed Sep 24, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-025816 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 23, 2021 Filed Sep 24, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $200.47 | $801,880.00 |
DisclosureSEC source: 0001127602-21-025816 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 23, 2021 Filed Sep 24, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-025816 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:37 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-025688 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:37 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $198.83 | $795,320.00 |
DisclosureSEC source: 0001127602-21-025688 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:37 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-025688 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 16, 2021 Filed Sep 17, 2021 20:39 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-025505 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 16, 2021 Filed Sep 17, 2021 20:39 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $205.14 | $820,560.00 |
DisclosureSEC source: 0001127602-21-025505 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 16, 2021 Filed Sep 17, 2021 20:39 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-025505 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 20:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-025338 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 20:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $208.47 | $833,880.00 |
DisclosureSEC source: 0001127602-21-025338 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 20:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-025338 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 21:39 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-025152 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 21:39 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $210.89 | $843,560.00 |
DisclosureSEC source: 0001127602-21-025152 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 21:39 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-025152 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 22:19 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-025033 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 22:19 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $207.98 | $831,920.00 |
DisclosureSEC source: 0001127602-21-025033 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 22:19 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-025033 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 02, 2021 Filed Sep 2, 2021 21:24 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-024791 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 02, 2021 Filed Sep 2, 2021 21:24 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $212.31 | $849,240.00 |
DisclosureSEC source: 0001127602-21-024791 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| September 02, 2021 Filed Sep 2, 2021 21:24 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-024791 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-024680 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $214.88 | $859,520.00 |
DisclosureSEC source: 0001127602-21-024680 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-024680 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-024413 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $205.75 | $823,000.00 |
DisclosureSEC source: 0001127602-21-024413 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-024413 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 24, 2021 Filed Aug 24, 2021 22:27 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-024267 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 24, 2021 Filed Aug 24, 2021 22:27 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $205.55 | $822,200.00 |
DisclosureSEC source: 0001127602-21-024267 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 24, 2021 Filed Aug 24, 2021 22:27 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-024267 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-024116 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $201.05 | $804,200.00 |
DisclosureSEC source: 0001127602-21-024116 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-024116 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-023981 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $203.74 | $814,960.00 |
DisclosureSEC source: 0001127602-21-023981 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.